We compared the protection afforded by three different DNA application
methods against bovine respiratory syncytial virus (BRSV) infection i
n cattle. A synthetic gene that codes for the G protein of BRSV was in
serted into a eukaryotic vector and was used in the vaccine. Intraderm
al (i.d.) application with a needleless injector (NI), the pigjet(TM)
reduced BRSV excretion significantly better after BRSV challenge than
intra-muscular (i.m.) or i.d. vaccination with a needle, Serum antibod
ies against the G protein were consistently the highest and showed les
s variation in calves vaccinated with the NI compared with those in i.
m. and i.d. vaccinated calves. After BRSV challenge, secondary serum a
nd mucosal antibody responses were also the highest in NI vaccinated c
alves. We conclude that DNA application with the needleless injector i
s substantially better than im. or i.d. application and is capable to
prime the immune response at the respiratory mucosa, (C) 1997 Elsevier
Science Ltd All rights reserved.